News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,956 Results
Type
Article (39596)
Company Profile (247)
Press Release (657113)
Multimedia
Podcasts (46)
Webinars (12)
Section
Business (204114)
Career Advice (2007)
Deals (35412)
Drug Delivery (95)
Drug Development (81022)
Employer Resources (172)
FDA (16165)
Job Trends (14848)
News (345087)
Policy (32513)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2553)
Accelerated approval (5)
Adcomms (20)
Allergies (81)
Alliances (49389)
ALS (85)
Alzheimer's disease (1365)
Antibody-drug conjugate (ADC) (111)
Approvals (16165)
Artificial intelligence (237)
Autoimmune disease (19)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (175)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (258)
Cancer (2061)
Cardiovascular disease (164)
Career advice (1674)
Career pathing (29)
CAR-T (143)
Cell therapy (400)
Cervical cancer (19)
Clinical research (65805)
Collaboration (780)
Compensation (497)
Complete response letters (19)
COVID-19 (2581)
CRISPR (37)
C-suite (221)
Cystic fibrosis (100)
Data (2032)
Decentralized trials (2)
Denatured (17)
Depression (39)
Diabetes (255)
Diagnostics (6347)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (117)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (88)
Earnings (86281)
Editorial (33)
Employer branding (21)
Employer resources (146)
Events (111819)
Executive appointments (674)
FDA (17318)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (706)
Gene editing (99)
Generative AI (19)
Gene therapy (282)
GLP-1 (692)
Government (4397)
Grass and pollen (4)
Guidances (50)
Healthcare (18810)
Huntington's disease (22)
IgA nephropathy (24)
Immunology and inflammation (105)
Indications (26)
Infectious disease (2719)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (90)
Interviews (311)
IPO (16493)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (35)
Layoffs (458)
Leadership (16)
Legal (7905)
Liver cancer (72)
Lung cancer (299)
Lymphoma (138)
Machine learning (5)
Management (58)
Manufacturing (275)
MASH (62)
Medical device (13335)
Medtech (13340)
Mergers & acquisitions (19423)
Metabolic disorders (650)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (82)
Neuropsychiatric disorders (24)
Neuroscience (1863)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2505)
Now hiring (37)
Obesity (349)
Opinion (203)
Ovarian cancer (73)
Pain (79)
Pancreatic cancer (79)
Parkinson's disease (144)
Partnered (21)
Patents (217)
Patient recruitment (99)
Peanut (46)
People (57166)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20495)
Phase II (28974)
Phase III (21599)
Pipeline (1094)
Policy (123)
Postmarket research (2563)
Preclinical (8667)
Press Release (64)
Prostate cancer (97)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (368)
Real estate (5905)
Recruiting (65)
Regulatory (22184)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (40)
Schizophrenia (65)
Series A (123)
Series B (80)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2162)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (62)
Tariffs (16)
The Weekly (27)
United States (21742)
Vaccines (661)
Venture capitalists (37)
Weight loss (227)
Women's health (34)
Worklife (15)
Date
Today (116)
Last 7 days (474)
Last 30 days (2388)
Last 365 days (33087)
2025 (8852)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31482)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (51)
Alaska (7)
Arizona (227)
Arkansas (13)
Asia (37737)
Australia (6174)
California (5699)
Canada (1921)
China (485)
Colorado (249)
Connecticut (262)
Delaware (132)
Europe (80959)
Florida (850)
Georgia (199)
Idaho (57)
Illinois (505)
India (24)
Indiana (296)
Iowa (9)
Japan (147)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (846)
Massachusetts (4282)
Michigan (214)
Minnesota (377)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (58)
New Hampshire (62)
New Jersey (1631)
New Mexico (28)
New York (1630)
North Carolina (931)
North Dakota (7)
Northern California (2505)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1287)
Puerto Rico (11)
Rhode Island (29)
South America (1095)
South Carolina (19)
South Dakota (1)
Southern California (2162)
Tennessee (96)
Texas (847)
Utah (170)
Virginia (135)
Washington D.C. (59)
Washington State (524)
West Virginia (3)
Wisconsin (51)
696,956 Results for "shouti inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
ShouTi’s Rationally Designed Small Molecules are Challenging Biologics and Peptides
ShouTi believes many targets addressed by biologic and peptide therapeutics can be reached by innovative, rationally-designed, best-in-class small molecules that don’t need refrigeration or injection.
May 17, 2022
·
4 min read
·
Gail Dutton
Business
ShouTi Appoints Sharon Tetlow to Board of Directors
ShouTi Inc., a clinical-stage global biopharmaceutical company developing novel oral therapeutics to treat a wide range of chronic diseases, announced the appointment of Sharon Tetlow to the company’s board of directors.
March 29, 2022
·
2 min read
Drug Development
Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi
Structure Therapeutics Inc. (Structure Therapeutics), formerly known as ShouTi Inc., today announced it closed an oversubscribed $33 million financing round, extending its $100 million Series B financing, which was announced in October 2021.
August 1, 2022
·
4 min read
Business
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships.
February 17, 2022
·
3 min read
Business
ShouTi Strengthens Board With Appointment of Daniel G. Welch as Chairman
ShouTi Inc., a clinical-stage biopharmaceutical company replacing biologics with world-class small molecule medicines using advanced computational and structure-based technology, announced that Daniel Welch has been named Chairman of the company’s board of directors.
January 20, 2022
·
3 min read
Business
ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer
ShouTi Inc., a clinical-stage biopharmaceutical company creating world-class small molecule medicines using advanced computational and structure-based technology, announced the appointment of Ding Ding, Ph.D., as Chief Financial Officer.
December 21, 2021
·
2 min read
Biotech Bay
ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
ShouTi Inc., today announced the close of a $100 million Series B financing led by BVF Partners L.P. (BVF).
October 20, 2021
·
4 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Press Releases
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio
April 14, 2025
·
9 min read
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
1 of 69,696
Next
